Mitchell H. Gold
2018
In 2018, Mitchell H. Gold earned a total compensation of $1M as Executive Chairman and Chief Executive Officer at Nivalis Therapeutics, a 56% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $130,000 |
|---|---|
| Option Awards | $512,630 |
| Salary | $400,000 |
| Other | $3,060 |
| Total | $1,045,690 |
Gold received $512.6K in option awards, accounting for 49% of the total pay in 2018.
Gold also received $130K in non-equity incentive plan, $400K in salary and $3.1K in other compensation.
Rankings
In 2018, Mitchell H. Gold's compensation ranked 9,008th out of 14,244 executives tracked by ExecPay. In other words, Gold earned more than 36.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,008 out of 14,244 | 37th |
Division Manufacturing | 3,587 out of 5,765 | 38th |
Major group Chemicals And Allied Products | 1,353 out of 2,128 | 36th |
Industry group Drugs | 1,136 out of 1,817 | 38th |
Industry Pharmaceutical Preparations | 885 out of 1,391 | 36th |
Source: SEC filing on April 24, 2019.
Gold's colleagues
We found three more compensation records of executives who worked with Mitchell H. Gold at Nivalis Therapeutics in 2018.